Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3706927014 | Interleukin 23 receptor antagonist (disposition) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3706928016 | Interleukin 23 receptor antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Interleukin 23 receptor antagonist (disposition) | Is a | Interleukin receptor antagonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tildrakizumab (substance) | Has disposition (attribute) | True | Interleukin 23 receptor antagonist (disposition) | Inferred relationship | Some | |
| Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Has disposition (attribute) | True | Interleukin 23 receptor antagonist (disposition) | Inferred relationship | Some | |
| Risankizumab | Has disposition (attribute) | True | Interleukin 23 receptor antagonist (disposition) | Inferred relationship | Some | |
| Mirikizumab (substance) | Has disposition (attribute) | True | Interleukin 23 receptor antagonist (disposition) | Inferred relationship | Some | |
| Ustekinumab (substance) | Has disposition (attribute) | True | Interleukin 23 receptor antagonist (disposition) | Inferred relationship | Some | |
| Guselkumab (substance) | Has disposition (attribute) | True | Interleukin 23 receptor antagonist (disposition) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR